JPS6041077B2
(ja)
|
1976-09-06 |
1985-09-13 |
喜徳 喜谷 |
1,2‐ジアミノシクロヘキサン異性体のシス白金(2)錯体
|
US4261989A
(en)
|
1979-02-19 |
1981-04-14 |
Kaken Chemical Co. Ltd. |
Geldanamycin derivatives and antitumor drug
|
JPS62135830A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
JPS62135832A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
JPS62135834A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
JPS62135835A
(ja)
|
1985-12-09 |
1987-06-18 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料の処理方法
|
JPS62136654A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料の処理方法
|
JPS62136651A
(ja)
|
1985-12-10 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラー写真感光材料の処理方法
|
JPS62136650A
(ja)
|
1985-12-11 |
1987-06-19 |
Fuji Photo Film Co Ltd |
ハロゲン化銀カラ−写真感光材料及びその処理方法
|
JPS62206545A
(ja)
|
1986-03-07 |
1987-09-11 |
Fuji Photo Film Co Ltd |
ハロゲン化銀写真感光材料
|
GB8729614D0
(en)
|
1987-12-18 |
1988-02-03 |
Beecham Group Plc |
Novel compounds
|
US5266573A
(en)
|
1989-08-07 |
1993-11-30 |
Elf Sanofi |
Trifluoromethylphenyltetrahydropyridines for the treatment and/or prophylaxis of intestinal motility disorders
|
US5360459A
(en)
|
1991-05-13 |
1994-11-01 |
The Lubrizol Corporation |
Copper-containing organometallic complexes and concentrates and diesel fuels containing same
|
JPH05196976A
(ja)
|
1991-11-18 |
1993-08-06 |
Toshiba Corp |
有機非線形光学材料
|
JPH05181221A
(ja)
|
1991-12-27 |
1993-07-23 |
Konica Corp |
ハロゲン化銀写真感光材料
|
GB9201755D0
(en)
|
1992-01-28 |
1992-03-11 |
British Bio Technology |
Compounds
|
FR2687932A1
(fr)
|
1992-02-27 |
1993-09-03 |
Oreal |
Dispersion huile-dans-l'eau susceptible de former des films composites.
|
EP0647450A1
(en)
|
1993-09-09 |
1995-04-12 |
BEHRINGWERKE Aktiengesellschaft |
Improved prodrugs for enzyme mediated activation
|
HRP970371A2
(en)
|
1996-07-13 |
1998-08-31 |
Kathryn Jane Smith |
Heterocyclic compounds
|
AU3785597A
(en)
|
1996-08-14 |
1998-03-06 |
Takeda Chemical Industries Ltd. |
Cyclic urea compounds, their production and use as herbicides
|
US5977134A
(en)
|
1996-12-05 |
1999-11-02 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
US6117973A
(en)
|
1997-02-24 |
2000-09-12 |
Georgia Tech Research Corp. |
PNA monomers with electron donor or acceptor
|
FR2761687B1
(fr)
|
1997-04-08 |
2000-09-15 |
Centre Nat Rech Scient |
Derives de quinoleines, possedant notamment des proprietes antivirales, leurs preparations et leurs applications biologiques
|
JP2000072695A
(ja)
|
1998-08-24 |
2000-03-07 |
Sumitomo Pharmaceut Co Ltd |
環状化合物
|
DE60024986T2
(de)
|
1999-05-21 |
2006-07-27 |
Biovitrum Ab |
Pyrazinyl-piperazin-verbindungen, ihre anwendung und herstellung
|
US6465467B1
(en)
|
1999-05-21 |
2002-10-15 |
Biovitrum Ab |
Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases
|
PE20010306A1
(es)
|
1999-07-02 |
2001-03-29 |
Agouron Pharma |
Compuestos de indazol y composiciones farmaceuticas que los contienen utiles para la inhibicion de proteina kinasa
|
AU6621600A
(en)
|
1999-08-04 |
2001-03-05 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
US6699873B1
(en)
|
1999-08-04 |
2004-03-02 |
Millennium Pharmaceuticals, Inc. |
Melanocortin-4 receptor binding compounds and methods of use thereof
|
US6514964B1
(en)
|
1999-09-27 |
2003-02-04 |
Amgen Inc. |
Fused cycloheptane and fused azacycloheptane compounds and their methods of use
|
IL148631A0
(en)
|
1999-09-28 |
2002-09-12 |
Eisai Co Ltd |
Quinuclidine derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
|
GB0018891D0
(en)
|
2000-08-01 |
2000-09-20 |
Novartis Ag |
Organic compounds
|
JP4548761B2
(ja)
|
2000-06-15 |
2010-09-22 |
富士フイルムホールディングス株式会社 |
潤滑剤組成物
|
WO2002000651A2
(en)
|
2000-06-27 |
2002-01-03 |
Bristol-Myers Squibb Pharma Company |
Factor xa inhibitors
|
DE10032633A1
(de)
|
2000-07-05 |
2002-01-17 |
Bayer Ag |
Verfahren zum Auffinden von Hemmstoffen der Protoporphyrinogen-Oxidase
|
JP2002122954A
(ja)
|
2000-08-08 |
2002-04-26 |
Fuji Photo Film Co Ltd |
感光性ハロゲン化銀写真乳剤、これを含有するハロゲン化銀写真感光材料および感光性ハロゲン化銀写真乳剤の感度向上方法
|
AU2001279955A1
(en)
|
2000-08-18 |
2002-03-04 |
Sterix Limited |
2-substituted estradiol derivative for inhibiting superoxid dismutase
|
US6963001B2
(en)
|
2000-09-30 |
2005-11-08 |
Henkel Corporation |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
WO2002028813A1
(en)
|
2000-09-30 |
2002-04-11 |
Loctite |
Low shrinkage thermosetting resin compositions and methods of use therefor
|
WO2002030358A2
(en)
|
2000-10-11 |
2002-04-18 |
Tularik Inc. |
Modulation of ccr4 function
|
EP1217000A1
(en)
|
2000-12-23 |
2002-06-26 |
Aventis Pharma Deutschland GmbH |
Inhibitors of factor Xa and factor VIIa
|
US6995162B2
(en)
|
2001-01-12 |
2006-02-07 |
Amgen Inc. |
Substituted alkylamine derivatives and methods of use
|
BR0206513A
(pt)
|
2001-01-16 |
2004-01-06 |
Astrazeneca Ab |
Composição, métodos de tratamento de um ser humano ou animal que sofre de depressão, ansiedade generalizada, distúrbios da alimentação, demência, distúrbio do p nico, distúrbios do sono, distúrbios gastrointestinais, distúrbios motores, distúrbios endócrinos, vasoespasmo e disfunção sexual, uso de qualquer um dos compostos, composição farmacêutica, e, processo para preparar compostos
|
AU2002217742B2
(en)
|
2001-01-16 |
2008-02-21 |
Astrazeneca Ab |
Therapeutic heterocyclic compounds
|
SE0103646D0
(sv)
|
2001-11-01 |
2001-11-01 |
Astrazeneca Ab |
Therapeutic chroman compounds
|
JP3616628B2
(ja)
|
2001-03-01 |
2005-02-02 |
塩野義製薬株式会社 |
Hivインテグラーゼ阻害活性を有する含窒素芳香族複素環化合物
|
PT1383731E
(pt)
|
2001-04-06 |
2009-11-03 |
Biocryst Pharm Inc |
Compostos de biarilo como inibidores de serina-protease
|
WO2003003008A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Chemical libraries useful for drug discovery processes
|
WO2003003009A1
(en)
|
2001-06-29 |
2003-01-09 |
7Tm Pharma A/S |
Use of metal-ion chelates in validating biological molecules as drug targets in test animal models
|
JO3429B1
(ar)
|
2001-08-13 |
2019-10-20 |
Janssen Pharmaceutica Nv |
مشتقات برميدينات مثبطة فيروس الايدز
|
US6897208B2
(en)
|
2001-10-26 |
2005-05-24 |
Aventis Pharmaceuticals Inc. |
Benzimidazoles
|
FR2831536A1
(fr)
|
2001-10-26 |
2003-05-02 |
Aventis Pharma Sa |
Nouveaux derives de benzimidazoles, leur procede de preparation, leur application a titre de medicament, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de kdr
|
US20030187026A1
(en)
|
2001-12-13 |
2003-10-02 |
Qun Li |
Kinase inhibitors
|
AU2003210787B2
(en)
|
2002-02-01 |
2009-04-23 |
Medinol Ltd. |
Phosphorus-containing compounds & uses thereof
|
PT1482924E
(pt)
|
2002-03-05 |
2008-08-27 |
Axys Pharm Inc |
Inibidores de proteases da cisteína catepsina
|
AU2003218629A1
(en)
|
2002-03-15 |
2003-09-29 |
Nuevolution A/S |
A building block forming a c-c or a c-hetero atom bond uponreaction
|
TWI275390B
(en)
|
2002-04-30 |
2007-03-11 |
Wyeth Corp |
Process for the preparation of 7-substituted-3- quinolinecarbonitriles
|
CN1678303A
(zh)
|
2002-08-23 |
2005-10-05 |
康涅狄格大学 |
具有治疗作用的酮类***类
|
WO2004056746A1
(en)
|
2002-12-23 |
2004-07-08 |
4Sc Ag |
Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
|
TWI344955B
(en)
|
2003-03-14 |
2011-07-11 |
Ono Pharmaceutical Co |
Heterocyclic rinf having nitrogen atom derivatives and medicament containing the derivatives as active ingredient
|
GB0306430D0
(en)
|
2003-03-20 |
2003-04-23 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalysts
|
BRPI0410348A
(pt)
|
2003-05-14 |
2006-05-30 |
Torreypines Therapeutics Inc |
compostos e usos dos mesmos na modulação de amilóide-beta
|
JPWO2004101529A1
(ja)
|
2003-05-19 |
2006-07-13 |
小野薬品工業株式会社 |
含窒素複素環化合物およびその医薬用途
|
US7399865B2
(en)
|
2003-09-15 |
2008-07-15 |
Wyeth |
Protein tyrosine kinase enzyme inhibitors
|
JP4231379B2
(ja)
|
2003-10-15 |
2009-02-25 |
富士フイルム株式会社 |
潤滑剤組成物
|
JP2005170939A
(ja)
|
2003-11-20 |
2005-06-30 |
Takeda Chem Ind Ltd |
糖尿病の予防・治療剤
|
DE10355066A1
(de)
|
2003-11-25 |
2005-06-23 |
Basf Ag |
Verfahren zur asymmetrischen Synthese
|
US7632946B2
(en)
|
2004-02-06 |
2009-12-15 |
Abbott Laboratories |
Naphthyridine-based antibacterial compositions
|
JP4829506B2
(ja)
|
2004-02-17 |
2011-12-07 |
石原産業株式会社 |
チオアミド系化合物又はその塩、並びにそれらを含有するサイトカイン産生抑制剤
|
WO2005099688A2
(en)
|
2004-04-07 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
Cyclic compounds
|
EP1595888A1
(en)
|
2004-05-11 |
2005-11-16 |
Degussa AG |
Cycloolefin phosphine ligands and their use in catalysis
|
GB0412467D0
(en)
|
2004-06-04 |
2004-07-07 |
Astrazeneca Ab |
Chemical compounds
|
JP5315611B2
(ja)
|
2004-06-23 |
2013-10-16 |
小野薬品工業株式会社 |
S1p受容体結合能を有する化合物およびその用途
|
GB0415879D0
(en)
|
2004-07-15 |
2004-08-18 |
Bp Chem Int Ltd |
Polymerisation catalyst
|
GB0418022D0
(en)
|
2004-08-12 |
2004-09-15 |
Bp Chem Int Ltd |
Polymerisation and oligomerisation catalyst
|
KR20150090263A
(ko)
|
2004-09-02 |
2015-08-05 |
제넨테크, 인크. |
헤지호그 신호전달에 대한 피리딜 억제제
|
GB0420396D0
(en)
|
2004-09-14 |
2004-10-13 |
Bp Chem Int Ltd |
Polyolefins
|
WO2006038594A1
(ja)
|
2004-10-04 |
2006-04-13 |
Ono Pharmaceutical Co., Ltd. |
N型カルシウムチャネル阻害薬
|
WO2006061094A1
(en)
|
2004-12-11 |
2006-06-15 |
Merck Patent Gmbh |
Liquid crystal compounds, liquid crystal medium and liquid crystal display
|
CA2594777A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Indoles useful in the treatment of inflamation
|
JP4749000B2
(ja)
|
2005-02-22 |
2011-08-17 |
富士フイルム株式会社 |
グリース組成物
|
US20070135437A1
(en)
|
2005-03-04 |
2007-06-14 |
Alsgen, Inc. |
Modulation of neurodegenerative diseases
|
US20080134938A1
(en)
|
2005-03-15 |
2008-06-12 |
Fujifilm Corporation |
Surface Treatment Method Employing Discotic Compound, (Lubricant) Composition to Be Used Surface Treatments, and Surface-Treated Articles
|
US20060156481A1
(en)
|
2005-03-22 |
2006-07-20 |
The Procter & Gamble Company |
Keratin dyeing compounds, keratin dyeing compositions containing them, and use thereof
|
US20070260062A1
(en)
|
2005-03-31 |
2007-11-08 |
Goetz Frederick J |
Heterocyclical Chromophore Architectures with Novel Electronic Acceptor Systems
|
BRPI0610035A2
(pt)
|
2005-04-21 |
2010-05-18 |
Serono Lab |
sulfonamidas de pirazina 2,3 substituìdas
|
ATE524467T1
(de)
|
2005-04-25 |
2011-09-15 |
Merck Patent Gmbh |
Neuartige aza-heterozyklen als kinase-inhibitoren
|
WO2006119800A1
(en)
|
2005-05-09 |
2006-11-16 |
Technische Universität Braunschweig |
Light emitting compound for electroluminescent applications
|
GB0510139D0
(en)
|
2005-05-18 |
2005-06-22 |
Addex Pharmaceuticals Sa |
Novel compounds B1
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
KR20080027890A
(ko)
|
2005-06-27 |
2008-03-28 |
브리스톨-마이어스 스큅 컴퍼니 |
혈전성 증상의 치료에 유용한 p2y1 수용체의 n-연결헤테로시클릭 길항제
|
EP1899299B1
(en)
|
2005-06-27 |
2010-10-20 |
Bristol-Myers Squibb Company |
C-linked cyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
|
WO2007011759A2
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
WO2007011721A1
(en)
|
2005-07-15 |
2007-01-25 |
Kalypsys, Inc. |
Inhibitors of mitotic kinesin
|
JP2007056213A
(ja)
|
2005-08-26 |
2007-03-08 |
Fujifilm Corp |
焼結含油軸受油用組成物、並びにそれを用いた軸受け装置及び摺動部材
|
NZ593684A
(en)
|
2005-10-19 |
2012-11-30 |
Gruenenthal Chemie |
Novel vanilloid receptor ligands and their use for producing medicaments
|
FR2892859B1
(fr)
|
2005-10-27 |
2008-06-06 |
Commissariat Energie Atomique |
Procede de greffage de molecules d'interet sur des surfaces inorganiques, surfaces obtenues et applications
|
EP1962892A4
(en)
|
2005-11-22 |
2011-10-12 |
Univ South Florida |
INHIBITION OF CELL PROLIFERATION
|
WO2007064869A2
(en)
|
2005-12-01 |
2007-06-07 |
Yale University |
Catalysts for aryl sulfide synthesis and method of producing aryl sulfides
|
JP2008007634A
(ja)
|
2006-06-29 |
2008-01-17 |
Fujifilm Corp |
潤滑剤組成物
|
CA2677001A1
(en)
|
2006-08-23 |
2008-02-28 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
WO2008028553A1
(en)
|
2006-09-02 |
2008-03-13 |
Merck Patent Gmbh |
Particle beam process for the alignment of reactive mesogens
|
WO2008118626A2
(en)
|
2007-03-08 |
2008-10-02 |
Burnham Institute For Medical Research |
Inhibitors of jnk and methods for identifying inhibitors of jnk
|
US7956020B2
(en)
|
2007-03-29 |
2011-06-07 |
Fujifilm Corporation |
Lubricant composition, mechanical element, and method for producing triazine derivatives
|
WO2008125811A1
(en)
|
2007-04-11 |
2008-10-23 |
Astrazeneca Ab |
N-[HETEROARYLCARBONYL]-S-THIENYL-L-ALANINE DERIVATIVES AS α5β1 ANTAGONISTS
|
EP2662353A3
(en)
|
2007-06-12 |
2014-04-02 |
Achaogen, Inc. |
Antibacterial agents
|
US8063165B2
(en)
|
2007-06-18 |
2011-11-22 |
Bridgestone Corporation |
Functional polymers prepared with sulfur-containing initiators
|
JP2009013314A
(ja)
|
2007-07-06 |
2009-01-22 |
Toyo Ink Mfg Co Ltd |
光硬化型インキ
|
US7939671B2
(en)
|
2007-08-21 |
2011-05-10 |
Senomyx, Inc. |
Compounds that inhibit (block) bitter taste in composition and use thereof
|
US8143276B2
(en)
|
2007-08-22 |
2012-03-27 |
Xtl Biopharmaceuticals Ltd. |
4-thio substituted quinoline and naphthyridine compounds
|
KR101504379B1
(ko)
|
2007-08-29 |
2015-03-19 |
메르크 파텐트 게엠베하 |
액정 디스플레이
|
EP2426108B1
(en)
|
2007-08-29 |
2016-08-10 |
MethylGene Inc. |
Processes and intermediates for preparing fused heterocyclic kinase inhibitors
|
MX338504B
(es)
|
2007-09-12 |
2016-04-20 |
Genentech Inc |
Combinaciones de compuestos inhibidores de fosfoinosituro 3-cinasa y agentes quimioterapeuticos, y metodos de uso.
|
EP2195304B1
(en)
|
2007-10-08 |
2014-01-08 |
Advinus Therapeutics Private Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
US9340506B2
(en)
|
2007-10-08 |
2016-05-17 |
Advinus Therapeutics Limited |
Acetamide derivatives as glucokinase activators, their process and medicinal applications
|
CA2701292C
(en)
|
2007-10-25 |
2015-03-24 |
Genentech, Inc. |
Process for making thienopyrimidine compounds
|
EP2217588A4
(en)
|
2007-11-02 |
2013-12-04 |
Methylgene Inc |
INHIBITORS OF HISTONE DEACETYLASE
|
WO2009078813A1
(en)
|
2007-12-19 |
2009-06-25 |
Nanyang Technological University |
Method of forming oseltamivir and derivatives thereof
|
EP2098226A1
(de)
|
2008-03-06 |
2009-09-09 |
Forschungsverbund Berlin e.V. |
AKAP-PKA-Interaktionshemmer zur Anwendung in der Behandlung von Herzkrankheiten
|
US8822513B2
(en)
|
2010-03-01 |
2014-09-02 |
Gtx, Inc. |
Compounds for treatment of cancer
|
US8168784B2
(en)
|
2008-06-20 |
2012-05-01 |
Abbott Laboratories |
Processes to make apoptosis promoters
|
US9174969B2
(en)
|
2008-07-21 |
2015-11-03 |
University Of South Florida |
Indoline scaffold SHP-2 inhibitors and cancer treatment method
|
WO2010012363A1
(en)
|
2008-07-28 |
2010-02-04 |
Merck Patent Gmbh |
Liquid-crystal display
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
DE102009055829A1
(de)
|
2008-12-22 |
2010-06-24 |
Merck Patent Gmbh |
Flüssigkristallanzeige
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
DE102010006691A1
(de)
|
2009-02-06 |
2010-10-28 |
Merck Patent Gmbh |
Flüssigkristallines Medium und Flüssigkristallanzeige
|
WO2010094029A2
(en)
|
2009-02-16 |
2010-08-19 |
University Of South Florida |
Asymmetric cyclopropanation with succinimidyl diazoacetate
|
EP2398474A4
(en)
|
2009-02-23 |
2012-12-05 |
Presidio Pharmaceuticals Inc |
HCV NS5A SHEMMER
|
JP2010217692A
(ja)
|
2009-03-18 |
2010-09-30 |
Konica Minolta Holdings Inc |
表示素子
|
SI2414369T1
(sl)
|
2009-04-02 |
2015-12-31 |
Fundacion Centro Nacional De Investigaciones Oncologicas Carlos Iii |
Derivati imidazo(2,1-b)(1,3,4)tiadiazola
|
US20120059179A1
(en)
|
2009-04-03 |
2012-03-08 |
The Scripps Research Insitiute |
Palladium-catalyzed ortho-fluorination
|
DE102010012900A1
(de)
|
2009-04-23 |
2010-11-25 |
Merck Patent Gmbh |
Flüssigkristallanzeige
|
CN102482277B
(zh)
|
2009-05-05 |
2017-09-19 |
达纳-法伯癌症研究所有限公司 |
表皮生长因子受体抑制剂及治疗障碍的方法
|
WO2011005355A1
(en)
|
2009-05-07 |
2011-01-13 |
Achaogen, Inc. |
Combinations comprising a lpxc inhibitor and an antibiotic for use in the treatment of infections caused by gram-negative bacteria
|
EP2443119A1
(en)
|
2009-06-16 |
2012-04-25 |
Schering Corporation |
Gamma secretase modulators
|
US20120238546A1
(en)
|
2009-06-16 |
2012-09-20 |
Zhaoning Zhu |
Gamma secretase modulators
|
WO2010147973A1
(en)
|
2009-06-16 |
2010-12-23 |
Schering Corporation |
Gamma secretase modulators
|
JP5732453B2
(ja)
|
2009-06-25 |
2015-06-10 |
アルカーメス ファーマ アイルランド リミテッド |
Nh酸性化合物のプロドラッグ
|
WO2010148422A1
(en)
|
2009-06-25 |
2010-12-29 |
Walter And Eliza Hall Institute Of Medical Research |
Compounds and methods for treating parasitic infestations
|
US20120149663A1
(en)
|
2009-08-18 |
2012-06-14 |
Georgetown University |
Boronic acid compositions and methods related to cancer
|
WO2011026579A1
(en)
|
2009-09-04 |
2011-03-10 |
Bayer Schering Pharma Aktiengesellschaft |
Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors
|
EP2292720A1
(en)
|
2009-09-08 |
2011-03-09 |
Merck Patent GmbH |
Liquid-crystal display
|
US8877930B2
(en)
|
2009-11-04 |
2014-11-04 |
Massachusetts Institute Of Technology |
Continuous flow synthesis of amino alcohols using microreactors
|
KR20110088098A
(ko)
|
2010-01-28 |
2011-08-03 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
CN102947302A
(zh)
|
2010-02-18 |
2013-02-27 |
西班牙国家癌症研究中心 |
***并[4,5-b]吡啶衍生物
|
MX2012010115A
(es)
|
2010-03-01 |
2013-02-26 |
Gtx Inc |
Compuestos para el tratamiento de cancer.
|
KR20110101444A
(ko)
|
2010-03-08 |
2011-09-16 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 포함하는 유기 발광 소자
|
KR20110104765A
(ko)
|
2010-03-17 |
2011-09-23 |
다우어드밴스드디스플레이머티리얼 유한회사 |
신규한 유기 발광 화합물 및 이를 채용하고 있는 유기 전계 발광 소자
|
US9725479B2
(en)
|
2010-04-22 |
2017-08-08 |
Ionis Pharmaceuticals, Inc. |
5′-end derivatives
|
CA2812526A1
(en)
|
2010-05-06 |
2011-11-10 |
Vertex Pharmaceuticals Incorporated |
Heterocyclic chromene-spirocyclic piperidine amides as modulators of ion channels
|
AU2011258217B2
(en)
|
2010-05-26 |
2016-12-15 |
Sunovion Pharmaceuticals Inc. |
Heteroaryl compounds and methods of use thereof
|
NZ605079A
(en)
|
2010-06-03 |
2015-08-28 |
Alnylam Pharmaceuticals Inc |
Biodegradable lipids for the delivery of active agents
|
NZ605692A
(en)
|
2010-07-29 |
2015-04-24 |
Rigel Pharmaceuticals Inc |
Ampk-activating heterocyclic compounds and methods for using the same
|
WO2012016133A2
(en)
|
2010-07-29 |
2012-02-02 |
President And Fellows Of Harvard College |
Ros1 kinase inhibitors for the treatment of glioblastoma and other p53-deficient cancers
|
US20130202652A1
(en)
|
2010-07-30 |
2013-08-08 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for delivery of active agents
|
WO2012020215A1
(en)
|
2010-08-09 |
2012-02-16 |
Centro Nacional De Investigaciones Oncológicas (Cnio) |
Amino- imidazolothiadiazoles for use as protein or lipid kinase inhibitors
|
WO2012020357A1
(en)
|
2010-08-09 |
2012-02-16 |
Advinus Therapeutics Ltd. |
Acetamide compounds, their process and pharmaceutical application
|
TW201211029A
(en)
|
2010-08-20 |
2012-03-16 |
Gruenenthal Gmbh |
Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor
|
WO2012049624A1
(en)
|
2010-10-14 |
2012-04-19 |
Koninklijke Philips Electronics N.V. |
Pretargeting kit, method and agents used therein
|
US9394290B2
(en)
|
2010-10-21 |
2016-07-19 |
Universitaet Des Saarlandes Campus Saarbruecken |
Selective CYP11B1 inhibitors for the treatment of cortisol dependent diseases
|
EP2632929A4
(en)
|
2010-10-28 |
2014-03-26 |
Basf Se |
N-heterocyclic carbene complexes and their preparation and use
|
US20120108819A1
(en)
|
2010-10-28 |
2012-05-03 |
Basf Se |
N-Heterocyclic Carbene Complexes, Their Preparation And Use
|
KR20120045905A
(ko)
|
2010-11-01 |
2012-05-09 |
한국화학연구원 |
헤테로고리 축합된 피리도 화합물 및 이의 제조방법
|
US9090633B2
(en)
|
2010-11-18 |
2015-07-28 |
Kasina Laila Innova Pharmaceuticals Private Limited |
Substituted 4-(arylamino) selenophenopyrimidine compounds and methods of use thereof
|
CN103298460B
(zh)
|
2010-12-14 |
2016-06-01 |
电泳有限公司 |
酪蛋白激酶1δ(CK1δ)抑制剂
|
WO2012085789A1
(en)
|
2010-12-21 |
2012-06-28 |
Koninklijke Philips Electronics N.V. |
Agents for clearing biomolecules from circulation
|
US8987271B2
(en)
|
2010-12-22 |
2015-03-24 |
Eutropics Pharmaceuticals, Inc. |
2,2′-biphenazine compounds and methods useful for treating disease
|
JP5618815B2
(ja)
|
2010-12-24 |
2014-11-05 |
富士フイルム株式会社 |
感活性光線性又は感放射線性樹脂組成物、並びに、この組成物を用いた感活性光線性又は感放射線性膜及びパターン形成方法
|
US8883793B2
(en)
|
2010-12-29 |
2014-11-11 |
Development Center For Biotechnology |
Tubulin inhibitors and methods of using the same
|
CA2827392A1
(en)
|
2011-02-24 |
2012-08-30 |
Emory University |
Noggin blocking compositions for ossification and methods related thereto
|
WO2012121973A1
(en)
|
2011-03-04 |
2012-09-13 |
Life Technologies Corporation |
Compounds and methods for conjugation of biomolecules
|
DE102012003796A1
(de)
|
2011-03-18 |
2012-09-20 |
Merck Patent Gmbh |
Flüssigkristallines Medium
|
US9464065B2
(en)
|
2011-03-24 |
2016-10-11 |
The Scripps Research Institute |
Compounds and methods for inducing chondrogenesis
|
KR102088166B1
(ko)
|
2011-03-29 |
2020-03-12 |
메르크 파텐트 게엠베하 |
액정 매질
|
JP2014511865A
(ja)
|
2011-04-07 |
2014-05-19 |
コーネル ユニバーシティー |
水溶液中で多量化できるシリル単量体、およびその使用法
|
EP2522369A1
(en)
|
2011-05-09 |
2012-11-14 |
Koninklijke Philips Electronics N.V. |
Pretargeting kit, method and agents used therein
|
CN103635230B
(zh)
|
2011-05-12 |
2017-10-31 |
普罗蒂斯特斯治疗公司 |
蛋白内稳态调节剂
|
ES2920373T3
(es)
|
2011-05-16 |
2022-08-03 |
Tagworks Pharmaceuticals B V |
Activación de fármaco bioortogonal
|
EP2524918A1
(en)
|
2011-05-19 |
2012-11-21 |
Centro Nacional de Investigaciones Oncológicas (CNIO) |
Imidazopyrazines derivates as kinase inhibitors
|
JP5782836B2
(ja)
|
2011-05-27 |
2015-09-24 |
コニカミノルタ株式会社 |
有機エレクトロルミネッセンス素子材料、有機エレクトロルミネッセンス素子、表示装置、照明装置、並びに化合物
|
US9073801B2
(en)
|
2011-06-03 |
2015-07-07 |
Massachusetts Institute Of Technology |
Z-selective ring-closing metathesis reactions
|
US9520565B2
(en)
|
2011-06-28 |
2016-12-13 |
Merck Patent Gmbh |
Indaceno derivatives as organic semiconductors
|
US9234136B2
(en)
|
2011-07-07 |
2016-01-12 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
US20140131628A1
(en)
|
2011-07-08 |
2014-05-15 |
Merck Patent Gmbh |
Conjugated polymers
|
CA2848147C
(en)
|
2011-09-09 |
2021-08-24 |
Lantheus Medical Imaging, Inc. |
Compositions, methods, and systems for the synthesis and use of imaging agents
|
CA2850166C
(en)
|
2011-09-27 |
2019-12-03 |
Amgen Inc. |
Heterocyclic compounds as mdm2 inhibitors for the treatment of cancer
|
EP2615083A1
(en)
|
2012-01-10 |
2013-07-17 |
Studiengesellschaft Kohle mbH |
Process for the asymmetric oxidation of organic compounds with peroxides in the presence of a chiral acid catalyst
|
JP5814141B2
(ja)
|
2012-01-23 |
2015-11-17 |
ユー・ディー・シー アイルランド リミテッド |
合成法、その合成法を用いて合成された化合物および有機電界発光素子
|
WO2013124040A1
(en)
|
2012-02-22 |
2013-08-29 |
Merck Patent Gmbh |
Liquid crystalline medium
|
US9217050B2
(en)
|
2012-04-03 |
2015-12-22 |
3M Innovative Properties Company |
Crosslinkable composition comprising photobase generators
|
EP2838893B1
(en)
|
2012-04-20 |
2019-03-13 |
Bayer Cropscience AG |
N-cycloalkyl-n-[(heterocyclylphenyl)methylene]-(thio)carboxamide derivatives
|
FR2992317B1
(fr)
|
2012-06-22 |
2016-05-13 |
Diverchim |
Procede de preparation de peptides chiraux
|
US8575283B1
(en)
|
2012-06-28 |
2013-11-05 |
Formosa Plastics Corporation, U.S.A. |
Heterocyclic organic compounds as electron donors for polyolefin catalysts
|
WO2014031872A2
(en)
|
2012-08-23 |
2014-02-27 |
The Broad Institute, Inc. |
Small molecule inhibitors for treating parasitic infections
|
RS61242B1
(sr)
|
2012-09-04 |
2021-01-29 |
Shanghai hengrui pharmaceutical co ltd |
Derivati imidazolina, postupci njihove pripreme i njihove primene u medicini
|
JP2015529242A
(ja)
|
2012-09-21 |
2015-10-05 |
アドヴィヌス セラピューティクス リミテッドAdvinus Therapeutics Limited |
置換された縮合三環式化合物、組成物およびその医薬用途
|
KR101677866B1
(ko)
|
2012-10-29 |
2016-11-18 |
코니카 미놀타 가부시키가이샤 |
위상차 필름, 원편광판 및 화상 표시 장치
|
KR20150086303A
(ko)
|
2012-11-16 |
2015-07-27 |
바스프 에스이 |
플루오로중합체 씰 상용성을 개선하기 위한 에폭시드 화합물을 포함하는 윤활제 조성물
|
EP2922574B1
(en)
|
2012-11-22 |
2023-05-17 |
Tagworks Pharmaceuticals B.V. |
Chemically cleavable group
|
US20150297741A1
(en)
|
2012-11-22 |
2015-10-22 |
Tagworks Pharmaceuticals B.V. |
Bio-orthogonal drug activation
|
WO2014081299A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Activatable liposomes
|
WO2014081300A1
(en)
|
2012-11-22 |
2014-05-30 |
Tagworks Pharmaceuticals B.V. |
Channel protein activatable liposomes
|
WO2014090362A1
(en)
|
2012-12-12 |
2014-06-19 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
JP6335428B2
(ja)
|
2012-12-21 |
2018-05-30 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
US20150340627A1
(en)
|
2013-01-03 |
2015-11-26 |
Merck Patent Gmbh |
Materials for electronic devices
|
WO2014122933A1
(ja)
|
2013-02-08 |
2014-08-14 |
ソニー株式会社 |
有機エレクトロルミネッセンス素子
|
EP2956441A4
(en)
|
2013-02-18 |
2016-11-02 |
Scripps Research Inst |
MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL
|
US9580400B2
(en)
|
2013-02-26 |
2017-02-28 |
Northeastern University |
Cannabinergic nitrate esters and related analogs
|
US9487472B2
(en)
|
2013-02-26 |
2016-11-08 |
President And Fellows Of Harvard College |
Synthesis of acyclic and cyclic amines using iron-catalyzed nitrene group transfer
|
US9963452B2
(en)
|
2013-03-14 |
2018-05-08 |
Augusta Pharmaceuticals Inc. |
Methods, compounds, and compositions for inhibition of ROS
|
US9290528B1
(en)
|
2013-03-15 |
2016-03-22 |
University Of Kentucky Research Foundation |
Light-activated compounds
|
JP5902641B2
(ja)
|
2013-03-27 |
2016-04-13 |
富士フイルム株式会社 |
光干渉顔料およびその製造方法
|
EP2981522A4
(en)
|
2013-04-05 |
2016-08-31 |
Salk Inst For Biological Studi |
ANTAGONISTS OF PPAR
|
CN105102581A
(zh)
|
2013-04-08 |
2015-11-25 |
默克专利有限公司 |
有机电致发光器件
|
WO2014166584A1
(de)
|
2013-04-08 |
2014-10-16 |
Merck Patent Gmbh |
Organische elektrolumineszenzvorrichtung mit thermisch aktiviertem verzögertem fluoreszenzmaterial
|
CA2944198C
(en)
|
2013-04-26 |
2021-11-16 |
Indiana University Research & Technology Corporation |
Hydroxyindole carboxylic acid based inhibitors for oncogenic src homology-2 domain containing protein tyrosine phosphatase-2 (shp2)
|
JP2014232188A
(ja)
|
2013-05-29 |
2014-12-11 |
コニカミノルタ株式会社 |
セルロースアシレートフィルム、円偏光板及び画像表示装置
|
EP3016652A4
(en)
|
2013-07-03 |
2017-03-08 |
Indiana University Research and Technology Corporation |
Shp2 inhibitors and methods of treating autoimmune and/or glomerulonephritis-associated diseases using shp2 inhibitors
|
US9862789B2
(en)
|
2013-07-03 |
2018-01-09 |
University Of Connecticut |
Polymerization of diene monomers
|
WO2015003146A1
(en)
|
2013-07-03 |
2015-01-08 |
Georgetown University |
Boronic acid derivatives of resveratrol for activating deacetylase enzymes
|
GB201312991D0
(en)
|
2013-07-19 |
2013-09-04 |
Isis Innovation |
Process
|
CN104371744B
(zh)
|
2013-08-02 |
2019-01-01 |
默克专利股份有限公司 |
液晶介质
|
US20160257657A1
(en)
|
2013-09-20 |
2016-09-08 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer
|
US20160229866A1
(en)
|
2013-09-20 |
2016-08-11 |
Idenix Pharmaceuticals Inc. |
Hepatitis c virus inhibitors
|
US20150087673A1
(en)
|
2013-09-26 |
2015-03-26 |
Rigel Pharmaceuticals, Inc. |
Methods for using and biomarkers for ampk-activating compounds
|
KR101628288B1
(ko)
|
2013-09-30 |
2016-06-08 |
주식회사 엘지화학 |
음성 광학 분산도를 갖는 광학 소자 제조용 조성물 및 이로부터 제조된 광학 이방체
|
EP2857405A1
(en)
|
2013-10-01 |
2015-04-08 |
Studiengesellschaft Kohle mbH |
Process for the trans-selective hydroboration of internal alkynes
|
PT3060550T
(pt)
|
2013-10-21 |
2019-08-27 |
Merck Patent Gmbh |
Compostos de heteroarilo como inibidores de btk e utilizações dos mesmos
|
JP6088995B2
(ja)
|
2013-10-24 |
2017-03-01 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
JP6522313B2
(ja)
|
2013-10-24 |
2019-05-29 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
KR101537860B1
(ko)
|
2013-11-22 |
2015-07-20 |
롯데케미칼 주식회사 |
내감마선 성능이 향상된 폴리카보네이트 수지 조성물 및 이를 이용한 성형품
|
JP6215674B2
(ja)
|
2013-11-29 |
2017-10-18 |
出光興産株式会社 |
有機エレクトロルミネッセンス素子および電子機器
|
JP6309834B2
(ja)
|
2013-12-11 |
2018-04-11 |
株式会社Adeka |
着色性組成物
|
JP2015163671A
(ja)
|
2013-12-13 |
2015-09-10 |
株式会社Adeka |
ラジカル重合性組成物
|
KR20150070027A
(ko)
|
2013-12-16 |
2015-06-24 |
메르크 파텐트 게엠베하 |
액정 매질
|
US10020455B2
(en)
|
2014-01-07 |
2018-07-10 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Tetradentate platinum and palladium complex emitters containing phenyl-pyrazole and its analogues
|
JP6510539B2
(ja)
|
2014-01-09 |
2019-05-08 |
ザ ジェイ. デヴィッド グラッドストーン インスティテューツ, ア テスタメンタリー トラスト エスタブリッシュド アンダー ザ ウィル オブ ジェイ. デヴィッド グラッドストーン |
置換ベンゾオキサジン及び関連化合物
|
EP3094629B1
(en)
|
2014-01-17 |
2018-08-22 |
Novartis AG |
1-(triazin-3-yl/pyridazin-3-yl)-piper(-azine)idine derivatives and compositions thereof for inhibiting the activity of shp2
|
WO2015107493A1
(en)
|
2014-01-17 |
2015-07-23 |
Novartis Ag |
1 -pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and and compositions thereof for inhibiting the activity of shp2
|
JO3517B1
(ar)
|
2014-01-17 |
2020-07-05 |
Novartis Ag |
ان-ازاسبيرو الكان حلقي كبديل مركبات اريل-ان مغايرة وتركيبات لتثبيط نشاط shp2
|
KR20150091942A
(ko)
|
2014-02-04 |
2015-08-12 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
JP6313604B2
(ja)
|
2014-02-05 |
2018-04-18 |
富士フイルム株式会社 |
感活性光線性又は感放射線性樹脂組成物、感活性光線性又は感放射線性膜、感活性光線性又は感放射線性膜を備えたマスクブランクス、パターン形成方法、及び電子デバイスの製造方法
|
CN106255679B
(zh)
|
2014-02-27 |
2019-09-06 |
默克专利有限公司 |
用作nav通道抑制剂的杂环化合物及其用途
|
CA2941716A1
(en)
|
2014-03-07 |
2015-09-11 |
The Johns Hopkins University |
Inhibitors of histone lysine specific demethylase (lsd1) and histone deacetylases (hdacs)
|
HUE053939T2
(hu)
|
2014-05-13 |
2021-08-30 |
Hoffmann La Roche |
Deuterált heterociklikus vegyületek és képalkotó kontrasztanyagként való használatuk
|
AU2015258904A1
(en)
|
2014-05-16 |
2016-11-17 |
Liqwd, Inc. |
Keratin treatment formulations and methods
|
NZ726874A
(en)
|
2014-05-19 |
2018-03-23 |
Merial Inc |
Anthelmintic compounds
|
US9399623B2
(en)
|
2014-06-05 |
2016-07-26 |
Merck Patent Gmbh |
Quinoline derivatives and their use in neurodegenerative diseases
|
SG11201700349SA
(en)
|
2014-07-16 |
2017-02-27 |
Agency Science Tech & Res |
Donor-acceptor polymers
|
US9818959B2
(en)
|
2014-07-29 |
2017-11-14 |
Arizona Board of Regents on behlaf of Arizona State University |
Metal-assisted delayed fluorescent emitters containing tridentate ligands
|
WO2016022645A1
(en)
|
2014-08-06 |
2016-02-11 |
Merck Sharp & Dohme Corp. |
Heterocyclic cgrp receptor antagonists
|
EP2985334B1
(en)
|
2014-08-15 |
2018-06-20 |
Merck Patent GmbH |
Liquid-crystalline medium
|
US9947876B2
(en)
|
2014-08-26 |
2018-04-17 |
Idemitsu Kosan Co., Ltd. |
Organic electroluminescence device and electronic device
|
EP2991153B1
(en)
|
2014-08-28 |
2023-08-23 |
Samsung Electronics Co., Ltd. |
Composite electrolyte and lithium battery including the same
|
WO2016049565A1
(en)
|
2014-09-25 |
2016-03-31 |
Araxes Pharma Llc |
Compositions and methods for inhibition of ras
|
AU2015360416A1
(en)
|
2014-12-10 |
2017-06-08 |
Massachusetts Institute Of Technology |
Fused 1,3-azole derivatives useful for the treatment of proliferative diseases
|
KR102384224B1
(ko)
|
2014-12-30 |
2022-04-08 |
삼성전자주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
WO2016145383A1
(en)
|
2015-03-11 |
2016-09-15 |
Board Of Regents, University Of Texas System |
Mth1 inhibitors for treating disease
|
KR102434696B1
(ko)
|
2015-03-13 |
2022-08-22 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
TW201702232A
(zh)
|
2015-04-10 |
2017-01-16 |
亞瑞克西斯製藥公司 |
經取代之喹唑啉化合物及其使用方法
|
US10428064B2
(en)
|
2015-04-15 |
2019-10-01 |
Araxes Pharma Llc |
Fused-tricyclic inhibitors of KRAS and methods of use thereof
|
TN2017000464A1
(en)
|
2015-05-07 |
2019-04-12 |
Bristol Myers Squibb Co |
Tricyclic sulfones as rorϒ modulators
|
US9458308B1
(en)
|
2015-05-12 |
2016-10-04 |
Lotte Chemical Corporation |
Polycarbonate resin composition with increased gamma-radiation resistant property and molded article using the same
|
US9879039B2
(en)
|
2015-06-03 |
2018-01-30 |
Arizona Board Of Regents On Behalf Of Arizona State University |
Tetradentate and octahedral metal complexes containing naphthyridinocarbazole and its analogues
|
CN107922388B
(zh)
|
2015-06-19 |
2020-12-29 |
诺华股份有限公司 |
用于抑制shp2活性的化合物和组合物
|
JP6878316B2
(ja)
*
|
2015-06-19 |
2021-05-26 |
ノバルティス アーゲー |
Shp2の活性を阻害するための化合物および組成物
|
US10975080B2
(en)
|
2015-06-19 |
2021-04-13 |
Novartis Ag |
Compounds and compositions for inhibiting the activity of SHP2
|
FR3037952B1
(fr)
|
2015-06-24 |
2019-01-25 |
Compagnie Generale Des Etablissements Michelin |
Procede de synthese d'oximes aromatiques
|
EP3112440B1
(en)
|
2015-07-02 |
2019-07-24 |
Merck Patent GmbH |
Liquid-crystal medium
|
MX2018000777A
(es)
|
2015-07-22 |
2018-03-23 |
Araxes Pharma Llc |
Compuestos de quinazolina sustituido y su uso como inhibidores de proteinas kras, hras y/o nras mutantes g12c.
|
GB201514018D0
(en)
|
2015-08-07 |
2015-09-23 |
Arnér Elias S J And United States Of America Asrepresented By The Sec Dep Of Health And Human Servic |
Novel tricyclic compounds and their use in the treatment of cancer
|
GB201514015D0
(en)
|
2015-08-07 |
2015-09-23 |
Arnér Elias S J And Dept Of Health And Human Services |
Novel pyridazinones and their use in the treatment of cancer
|
US10201531B2
(en)
|
2015-08-12 |
2019-02-12 |
Mochida Pharmaceutical Co., Ltd. |
Indazolyl-oxo-isothiazole compounds
|
EP3133078B1
(en)
|
2015-08-18 |
2019-01-30 |
Samsung Electronics Co., Ltd. |
Organometallic compound and organic light-emitting device including the same
|
KR101796227B1
(ko)
|
2015-08-21 |
2017-11-10 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
US10240085B2
(en)
|
2015-08-27 |
2019-03-26 |
Samsung Electronics Co., Ltd. |
Thin film and organic light-emitting device including the same
|
KR102542465B1
(ko)
|
2015-09-22 |
2023-06-12 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
WO2017058915A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
WO2017058768A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
EP3356339A1
(en)
|
2015-09-28 |
2018-08-08 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
US10882847B2
(en)
|
2015-09-28 |
2021-01-05 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
WO2017058807A1
(en)
|
2015-09-28 |
2017-04-06 |
Araxes Pharma Llc |
Inhibitors of kras g12c mutant proteins
|
US10858343B2
(en)
|
2015-09-28 |
2020-12-08 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
US10730867B2
(en)
|
2015-09-28 |
2020-08-04 |
Araxes Pharma Llc |
Inhibitors of KRAS G12C mutant proteins
|
SE541053C2
(sv)
|
2015-09-30 |
2019-03-19 |
Epiroc Rock Drills Ab |
System och förfarande för borrplansgenerering, borrigg, datorprogram samt datorprogramprodukt
|
WO2017066705A1
(en)
|
2015-10-14 |
2017-04-20 |
Aquinnah Pharmaceuticals, Inc. |
Compounds, compositions and methods of use against stress granules
|
WO2017070256A2
(en)
|
2015-10-19 |
2017-04-27 |
Araxes Pharma Llc |
Method for screening inhibitors of ras
|
EP3162875B1
(en)
|
2015-10-30 |
2018-05-23 |
Merck Patent GmbH |
Polymerisable compounds and the use thereof in liquid-crystal displays
|
EP3371172B1
(en)
|
2015-11-02 |
2021-10-20 |
Genase Therapeutics B.V. |
Tetrahydroindazoles and medical uses thereof
|
JP7015059B2
(ja)
|
2015-11-16 |
2022-02-15 |
アラクセス ファーマ エルエルシー |
置換複素環式基を含む2-置換キナゾリン化合物およびその使用方法
|
WO2017100546A1
(en)
|
2015-12-09 |
2017-06-15 |
Araxes Pharma Llc |
Methods for preparation of quinazoline derivatives
|
KR20170069342A
(ko)
|
2015-12-10 |
2017-06-21 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
CN106892924B
(zh)
|
2015-12-17 |
2021-01-08 |
四川科伦博泰生物医药股份有限公司 |
短效苯并二氮*衍生物、其制备方法及其用途
|
KR20170075118A
(ko)
|
2015-12-22 |
2017-07-03 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR102579752B1
(ko)
|
2015-12-22 |
2023-09-19 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
US10336772B2
(en)
|
2015-12-28 |
2019-07-02 |
Samsung Electronics Co., Ltd. |
Bicarbazole compound, material for organic light-emitting device including bicarbazole compound, and organic light-emitting device including bicarbazole compound
|
KR102396293B1
(ko)
|
2015-12-29 |
2022-05-11 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR102419178B1
(ko)
|
2015-12-29 |
2022-07-11 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
WO2017117239A1
(en)
|
2015-12-30 |
2017-07-06 |
Flatley Discovery Lab, Llc |
Compounds and methods for the treatment of cystic fibrosis
|
EP3190164B1
(en)
|
2016-01-05 |
2019-07-24 |
Samsung Electronics Co., Ltd |
Composition, thin film including the composition, and organic light-emitting device including the composition or the thin film
|
KR102633852B1
(ko)
|
2016-01-25 |
2024-02-07 |
삼성디스플레이 주식회사 |
카바졸계 화합물 및 이를 포함한 유기 발광 소자
|
CN109071374A
(zh)
|
2016-02-08 |
2018-12-21 |
Aaa化学公司 |
脂肪胺的芳基化
|
KR102628850B1
(ko)
|
2016-03-07 |
2024-01-25 |
삼성디스플레이 주식회사 |
축합환 화합물 및 이를 포함한 유기 발광 소자
|
US11179710B2
(en)
|
2016-03-09 |
2021-11-23 |
President And Fellows Of Harvard College |
Direct palladium-catalyzed aromatic fluorination
|
EP3429591B1
(en)
|
2016-03-16 |
2023-03-15 |
Kura Oncology, Inc. |
Substituted thieno[2,3-d]pyrimidine derivatives as inhibitors of menin-mll and methods of use
|
WO2017172979A1
(en)
|
2016-03-30 |
2017-10-05 |
Araxes Pharma Llc |
Substituted quinazoline compounds and methods of use
|
CN108780273B
(zh)
|
2016-03-31 |
2022-06-28 |
Dnp精细化工股份有限公司 |
感光性着色树脂组合物、滤色器及其制造方法以及显示设备
|
KR102606277B1
(ko)
|
2016-04-06 |
2023-11-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
KR102642199B1
(ko)
|
2016-04-07 |
2024-03-05 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
ES2863873T3
(es)
|
2016-05-18 |
2021-10-11 |
Mirati Therapeutics Inc |
Inhibidores de KRAS G12C
|
JP7044375B2
(ja)
|
2016-05-31 |
2022-03-30 |
ボード オブ リージェンツ,ザ ユニバーシティ オブ テキサス システム |
Ptpn11の複素環式阻害剤
|
SG10202110874TA
(en)
|
2016-06-07 |
2021-11-29 |
Jacobio Pharmaceuticals Co Ltd |
Novel heterocyclic derivatives useful as shp2 inhibitors
|
KR20170138614A
(ko)
|
2016-06-07 |
2017-12-18 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
ES2810852T3
(es)
|
2016-06-14 |
2021-03-09 |
Novartis Ag |
Compuestos y composiciones para inhibir la actividad de shp2
|
JP2019518063A
(ja)
|
2016-06-20 |
2019-06-27 |
クラ オンコロジー, インコーポレイテッド |
Erk阻害剤を用いた扁平上皮細胞癌の処置
|
US20180002604A1
(en)
|
2016-06-30 |
2018-01-04 |
Merck Patent Gmbh |
Liquid-crystalline medium
|
KR20230156174A
(ko)
*
|
2016-07-12 |
2023-11-13 |
레볼루션 메디슨즈, 인크. |
다른자리 입체성 shp2 억제제로서의 2,5-이치환 3-메틸 피라진 및 2,5,6-3치환 3-메틸 피라진
|
US11299673B2
(en)
|
2016-08-12 |
2022-04-12 |
Merck Patent Gmbh |
Liquid-crystal medium
|
KR20180019803A
(ko)
|
2016-08-16 |
2018-02-27 |
삼성디스플레이 주식회사 |
유기 발광 소자
|
EP3515916B1
(en)
|
2016-09-22 |
2023-06-07 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
JP6589795B2
(ja)
|
2016-09-27 |
2019-10-16 |
信越化学工業株式会社 |
スルホニウム塩、レジスト組成物及びパターン形成方法
|
CN109790468B
(zh)
|
2016-09-28 |
2023-06-13 |
默克专利股份有限公司 |
可聚合的液晶材料及经聚合的液晶膜
|
US11424410B2
(en)
|
2016-09-29 |
2022-08-23 |
Sumitomo Chemical Company, Limited |
Light emitting device
|
EP3519402A1
(en)
|
2016-09-29 |
2019-08-07 |
Araxes Pharma LLC |
Inhibitors of kras g12c mutant proteins
|
CN110312711A
(zh)
|
2016-10-07 |
2019-10-08 |
亚瑞克西斯制药公司 |
作为ras抑制剂的杂环化合物及其使用方法
|
KR102506326B1
(ko)
|
2016-10-13 |
2023-03-03 |
브리스톨-마이어스 스큅 컴퍼니 |
Ror 감마 조정제로서의 헤테로시클릭 술폰
|
TW201819386A
(zh)
|
2016-10-24 |
2018-06-01 |
美商傳達治療有限公司 |
Shp2磷酸酶抑制劑及其使用方法
|
US10435369B2
(en)
|
2016-11-09 |
2019-10-08 |
Bristol-Myers Squibb Company |
Tricyclic sulfones as ROR gamma modulators
|
RS62456B1
(sr)
|
2016-12-22 |
2021-11-30 |
Amgen Inc |
Derivati benzizotiazola, izotiazolo[3,4-b]piridina, hinazolina, ftalazina, pirido[2,3-d]piridazina i pirido[2,3-d]pirimidina kao kras g12c inhibitori za tretman raka pluća, pankreasa ili debelog creva
|
WO2018119263A1
(en)
|
2016-12-22 |
2018-06-28 |
Incyte Corporation |
Heterocyclic compounds derivatives as pd-l1 internalization inducers
|
CA3048340A1
(en)
|
2017-01-10 |
2018-07-19 |
Novartis Ag |
Pharmaceutical combination comprising an alk inhibitor and a shp2 inhibitor
|
CN110446709B
(zh)
|
2017-01-23 |
2023-09-12 |
锐新医药公司 |
作为变构shp2抑制剂的二环化合物
|
AU2018210196B2
(en)
|
2017-01-23 |
2022-06-02 |
Revolution Medicines, Inc. |
Pyridine compounds as allosteric SHP2 inhibitors
|
EP3580209A1
(en)
|
2017-02-07 |
2019-12-18 |
Oblique Therapeutics AB |
Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer
|
KR20190115013A
(ko)
|
2017-02-07 |
2019-10-10 |
오블리크 세러퓨틱스 에이비 |
헤테로아릴설포닐-치환된 피리딘 및 암의 치료에서 이의 용도
|
WO2018161033A1
(en)
|
2017-03-02 |
2018-09-07 |
Wright, Adrian |
Small molecule ire1-alpha inhibitors
|
EA201992253A1
(ru)
|
2017-03-23 |
2020-03-31 |
Джакобио Фармасьютикалс Ко., Лтд. |
Новые гетероциклические производные, применимые в качестве ингибиторов shp2
|
KR102395784B1
(ko)
|
2017-03-27 |
2022-05-10 |
삼성전자주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
KR102461719B1
(ko)
|
2017-05-23 |
2022-11-01 |
삼성전자주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
|
US11591336B2
(en)
|
2017-05-26 |
2023-02-28 |
D. E. Shaw Research, Llc |
Substituted pyrazolo[3,4-b]pyrazines as SHP2 phosphatase inhibitors
|
WO2018230595A1
(ja)
|
2017-06-14 |
2018-12-20 |
富士フイルム株式会社 |
組成物、膜、レンズ、固体撮像素子、化合物
|
KR20180137311A
(ko)
|
2017-06-16 |
2018-12-27 |
삼성전자주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
|
WO2019002173A1
(en)
|
2017-06-26 |
2019-01-03 |
Esteve Pharmaceuticals, S.A. |
COMPOUNDS HAVING MULTIMODAL ACTIVITY AGAINST PAIN
|
WO2019018119A1
(en)
|
2017-07-18 |
2019-01-24 |
Pairnomix, Llc |
METHODS FOR TREATING EPILEPSY AND DISORDERS ASSOCIATED WITH KCNTI
|
KR20190014187A
(ko)
|
2017-07-27 |
2019-02-12 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함하는 유기 발광 소자
|
GB201712110D0
(en)
|
2017-07-27 |
2017-09-13 |
Thomas Helledays Stiftelse För Medicinsk Forskning |
New compounds and uses
|
JP7346015B2
(ja)
|
2017-09-06 |
2023-09-19 |
住友化学株式会社 |
発光素子
|
WO2019051084A1
(en)
|
2017-09-07 |
2019-03-14 |
Revolution Medicines, Inc. |
SHP2 INHIBITOR COMPOSITIONS AND METHODS OF TREATING CANCER
|
EP3681879A1
(en)
|
2017-09-11 |
2020-07-22 |
Krouzon Pharmaceuticals, Inc. |
Octahydrocyclopenta[c]pyrrole allosteric inhibitors of shp2
|
KR102526756B1
(ko)
|
2017-09-29 |
2023-04-27 |
삼성전자주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 이를 포함한 진단용 조성물
|
EP3687997A1
(en)
|
2017-09-29 |
2020-08-05 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine derivatives as shp2 phosphatase inhibitors
|
CN111148819B
(zh)
|
2017-09-29 |
2023-06-16 |
默克专利股份有限公司 |
可聚合化合物及其在液晶显示器中的用途
|
RU2020115095A
(ru)
|
2017-10-12 |
2021-11-12 |
Революшн Медсинз, Инк. |
Пиридиновые, пиразиновые и триазиновые соединения в качестве аллостерических ингибиторов shp2
|
KR102518722B1
(ko)
|
2017-11-21 |
2023-04-07 |
삼성디스플레이 주식회사 |
유기금속 화합물 및 이를 포함한 유기 발광 소자
|
RU2020123241A
(ru)
|
2017-12-15 |
2022-01-17 |
Революшн Медсинз, Инк. |
Полициклические соединения в качестве аллостерических ингибиторов shp2
|
WO2019126730A1
(en)
|
2017-12-22 |
2019-06-27 |
Petra Pharma Corporation |
Chromenopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors
|
WO2019136442A1
(en)
|
2018-01-08 |
2019-07-11 |
Kleo Pharmaceuticals, Inc. |
Cd16a binding agents and uses thereof
|
KR102595918B1
(ko)
|
2018-01-18 |
2023-11-14 |
삼성디스플레이 주식회사 |
유기금속 화합물, 이를 포함한 유기 발광 소자 및 상기 유기 발광 소자를 포함한 유기 발광 장치
|
CN110066277B
(zh)
|
2018-01-24 |
2021-07-23 |
上海璎黎药业有限公司 |
芳香杂环取代烯烃化合物、其制备方法、药物组合物和应用
|
CN110066276B
(zh)
|
2018-01-24 |
2020-09-18 |
上海璎黎药业有限公司 |
芳香杂环化合物、其中间体、制备方法、药物组合物和应用
|
KR20190098676A
(ko)
|
2018-02-13 |
2019-08-22 |
삼성디스플레이 주식회사 |
유기 발광 소자 및 이를 포함한 표시 장치
|
KR102614939B1
(ko)
|
2018-02-13 |
2023-12-19 |
블루레이 테라퓨틱스 (상하이) 컴퍼니 리미티드 |
피리미딘-융합고리 화합물 및 그의 제조방법과 용도
|
US20200392161A1
(en)
|
2018-02-21 |
2020-12-17 |
Relay Therapeutics, Inc. |
Shp2 phosphatase inhibitors and methods of use thereof
|
SG11202006778TA
(en)
|
2018-03-02 |
2020-08-28 |
Otsuka Pharma Co Ltd |
Pharmaceutical compounds
|
EP3537495A1
(en)
|
2018-03-08 |
2019-09-11 |
Samsung Display Co., Ltd. |
Organic light-emitting device
|
EP3537493A1
(en)
|
2018-03-09 |
2019-09-11 |
Samsung Display Co., Ltd |
Electronic apparatus
|
WO2019182960A1
(en)
|
2018-03-21 |
2019-09-26 |
Synblia Therapeutics, Inc. |
Shp2 inhibitors and uses thereof
|
EP3768680A1
(en)
|
2018-03-21 |
2021-01-27 |
Relay Therapeutics, Inc. |
Pyrazolo[3,4-b]pyrazine shp2 phosphatase inhibitors and methods of use thereof
|
BR112020019385A2
(pt)
|
2018-03-21 |
2021-03-30 |
Relay Therapeutics, Inc. |
Inibidores de shp2 fosfatase e métodos de uso dos mesmos
|
CN108794485B
(zh)
|
2018-04-28 |
2020-04-24 |
北京施安泰医药技术开发有限公司 |
一类toll样受体调节剂、其药物组合物、制备方法与用途
|
SG11202010822SA
(en)
|
2018-05-02 |
2020-11-27 |
Navire Pharma Inc |
Substituted heterocyclic inhibitors of ptpn11
|
CN110492006B
(zh)
|
2018-05-14 |
2020-06-12 |
江苏三月光电科技有限公司 |
一种基于含硼有机化合物的电致发光器件
|
CN108840886A
(zh)
|
2018-06-22 |
2018-11-20 |
南京工业大学 |
一种铂配合物蓝光材料以及有机发光器件
|
EP3827009A4
(en)
|
2018-07-24 |
2022-04-27 |
Taiho Pharmaceutical Co., Ltd. |
HETEROBICYCLIC COMPOUNDS TO INHIBIT SHP2 ACTIVITY
|
CN108863982B
(zh)
|
2018-08-04 |
2022-02-01 |
南昌航空大学 |
一种吩噻嗪/吩恶嗪类化合物的有机电合成方法
|
US11518770B2
(en)
|
2018-08-06 |
2022-12-06 |
Purdue Research Foundation |
Sesquiterpenoid analogs
|
PE20211050A1
(es)
|
2018-08-10 |
2021-06-04 |
Navire Pharma Inc |
Inhibidores de ptpn11
|
US11459340B2
(en)
|
2018-09-18 |
2022-10-04 |
Nikang Therapeutics, Inc. |
Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors
|
CA3113379A1
(en)
|
2018-09-29 |
2020-04-02 |
Novartis Ag |
Process of manufacture of a compound for inhibiting the activity of shp2
|
WO2020065452A1
(en)
|
2018-09-29 |
2020-04-02 |
Novartis Ag |
Manufacture of compounds and compositions for inhibiting the activity of shp2
|
EP3863636A1
(en)
|
2018-10-08 |
2021-08-18 |
Revolution Medicines, Inc. |
Shp2 inhibitor compositions for use in treating cancer
|